Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis

Journal of Neuroimmunology

Volumn 235, Issue 1-2, 2011, Pages 104-109

  Heurich, Bianca ^a   el Idrissi, Nawal Bahia ^c   Donev, Rossen M ^a   Petri, Susanne ^d   Claus, Peter ^d   Neal, James ^b   Morgan, B Paul ^a   Ramaglia, Valeria ^a,c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Complement; Motor neurons; Neuromuscular junction

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3B; MESSENGER RNA;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL LOSS; CLINICAL FEATURE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FAMILIAL DISEASE; GENE CONTROL; IMMUNOREGULATION; MOTONEURON; MOUSE; MOUSE STRAIN; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SOD1 G93A MOUSE; SYMPTOM; UPREGULATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; COMPLEMENT C3; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC; MOTOR NEURONS; NEUROMUSCULAR JUNCTION; SUPEROXIDE DISMUTASE; UP-REGULATION;

EID: 79957990024     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.03.011     Document Type: Article

References (26)

1. Annunziata P., Volpi N. High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients. Acta Neurol. Scand. 1985, 72:61-64.
2. Apostolski S., Nikolic J., Bugarski-Prokopljevic C., Miletic V., Pavlovic S., Filipovic S. Serum and CSF immunological findings in ALS. Acta Neurol. Scand. 1991, 83:96-98.
3. de Jonge R.R., van Schaik I.N., Vreijling J.P., Troost D., Baas F. Expression of complement components in the peripheral nervous system. Hum. Mol. Genet. 2004, 13:295-302.
4. Donev R.M., Morgan B.P. A quantitative method for comparison of expression of alternatively spliced genes using different primer pairs. J. Biochem. Biophys. Methods 2006, 66:23-31.
5. Ferraiuolo L., Heath P.R., Holden H., Kasher P., Kirby J., Shaw P.J. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J. Neurosci. 2007, 27:9201-9219.
6. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 2004, 185:232-240.
7. Goldknopf I.L., Sheta E.A., Bryson J., Folsom B., Wilson C., Duty J., Yen A.A., Appel S.H. Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease. Biochem. Biophys. Res. Commun. 2006, 342:1034-1039.
8. Gong Y.H., Parsadanian A.S., Andreeva A., Snider W.D., Elliott J.L. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 2000, 20:660-665.
9. Griffiths M.R., Neal J.W., Fontaine M., Das T., Gasque P. Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis. J. Immunol. 2009, 182:4368-4377.
10. Gurney M.E. Transgenic-mouse model of amyotrophic lateral sclerosis. N. Engl. J. Med. 1994, 331:1721-1722.
11. Gurney M.E. Transgenic-mouse model of amyotrophic lateral sclerosis. N. Engl. J. Med. 1994, 331:1721-1722.
12. Halstead S.K., O'Hanlon G.M., Humphreys P.D., Morrison D.B., Morgan B.P., Todd A.J., Plomp J.J., Willison H.J. Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain 2004, 127:2109-2123.
13. Lobsiger C.S., Boillee S., Cleveland D.W. Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons. Proc. Natl. Acad. Sci. U. S. A 2007, 104:7319-7326.
14. Mitchell J.D., Borasio G.D. Amyotrophic lateral sclerosis. Lancet 2007, 369:2031-2041.
15. O'Hanlon G.M., Plomp J.J., Chakrabarti M., Morrison I., Wagner E.R., Goodyear C.S., Yin X., Trapp B.D., Conner J., Molenaar P.C., Stewart S., Rowan E.G., Willison H.J. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 2001, 124:893-906.
16. Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 2006, 7:710-723.
17. Pramatarova A., Laganiere J., Roussel J., Brisebois K., Rouleau G.A. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 2001, 21:3369-3374.
18. Ramaglia V., King R.H., Nourallah M., Wolterman R., de Jonge R., Ramkema M., Vigar M.A., Van der W.S., Morgan B.P., Troost D., Baas F. The membrane attack complex of the complement system is essential for rapid Wallerian degeneration. J. Neurosci. 2007, 27:7663-7672.
19. Ramaglia V., Tannemaat M.R., de K.M., Wolterman R., Vigar M.A., King R.H., Morgan B.P., Baas F. Complement inhibition accelerates regeneration in a model of peripheral nerve injury. Mol. Immunol. 2009, 47:302-309.
20. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
21. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., Sher A., Litke A.M., Lambris J.D., Smith S.J., John S.W., Barres B.A. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
22. Tsuboi Y., Yamada T. Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 1994, 57:859-861.
23. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344:1058-1066.
24. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 2001, 344:1140-1144.
25. Wang J., Ma J.H., Giffard R.G. Overexpression of copper/zinc superoxide dismutase decreases ischemia-like astrocyte injury. Free Radic. Biol. Med. 2005, 38:1112-1118.
26. Woodruff T.M., Costantini K.J., Crane J.W., Atkin J.D., Monk P.N., Taylor S.M., Noakes P.G. The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis. J. Immunol. 2008, 181:8727-8734.